Abstract: The disclosure provides for a biocompatible, thromboresistant coating including a chalcogenide compound that induces nitric oxide formation; and a biocompatible matrix incorporating the chalcogenide compound. Devices incorporating such coatings, and methods of making and using such coatings are also disclosed herein.
Type:
Application
Filed:
December 1, 2006
Publication date:
November 19, 2009
Applicants:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN, MICHIGAN CRITICAL CARE CONSULTANTS, INC. (MC3)
Inventors:
Mark E. Meyerhoff, Wansik Cha, Sang-Yeul Hwang, Melissa M. Reynolds